Endocrinology & Metabolic Syndrome
Open Access

Management of subclinical hypothyroidism and L-thyroxine treatment in susceptible patients: A systematic review

Joint Event on 11^th World Congress on Endocrinology and Metabolic Disorders and 2^nd International Conference on Thyroid & Pregnancy

September 03-04, 2018 Auckland, New Zealand

Haamid Bashir, Sabhiya Majid, Mohammad Hayat Bhat, Rabia Farooq, Rakesh Kumar Koul, Parvaiz Ahmad Shah and Rabia Hamid

University of Kashmir, India

Posters & Accepted Abstracts: Endocrinol Metab Syndr

Abstract :

Subclinical Hypothyroidism (SCH) is defined as the clinical status of elevated serum TSH levels (>10 mU/l)) with normal levels of serum thyroxine (T4) and triiodothyronine (T3) and is a more common disorder than primary hypothyroidism with a prevalence of 1.4-7.8% in older populations, prevalence being and even greater among women. The high prevalence depends upon age, gender and ethnic background. The untreated patients are followed up after two months and TSH was repeated and those with TSH value >10 mU/l are recommended L-thyroxine hormone replacement therapy. The patients, whose TSH values are at the normal range, are also recommended at least repeat TSH value annually. Also, patients are suggested to take iodized salt and diet rich in iodine locally available. Further, mass screening of thyroid profile is needed to be done at different populations and ethnic backgrounds.

Biography :

E-mail: haamidb7@gmail.com